|
Index of reports
> Cases resulting in life threatening events (87)
> Cases with Neuroleptic Malignant Syndrome (11)
Below is the selection of adverse event reports related to Zyprexa (Olanzapine) that includes cases resulting in life threatening events where reactions include neuroleptic malignant syndrome.
Adverse event in 26 year old male receiving Zyprexa (Olanzapine)
Reported by a pharmacist from United States on 2007-10-03
Patient: 26 year old male, weighing 91.2 kg (200.6 pounds)
Adverse reactions / side effects: Aspiration, Neuroleptic Malignant Syndrome, Respiratory Distress
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyprexa
Dosage: 15 mg bid po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2007-09-06
End date: 2007-09-10
Benztropine 1 MG
Dosage: 1 mg bid po
Administration route: Oral
Indication: Muscle Rigidity
Start date: 2007-09-04
End date: 2007-09-10
Adverse event in female receiving Zyprexa (Olanzapine)
Reported by a physician from Japan on 2007-07-27
Patient: female, weighing 38.0 kg (83.6 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Blood Creatine Phosphokinase Increased, Depressive Symptom, Hepatic Function Abnormal, Delusion of Reference, Pyrexia, Serotonin Syndrome, Muscle Tightness, Delusion, Hypokinesia, Thinking Abnormal, Neuroleptic Malignant Syndrome, Persecutory Delusion, Compulsions, Tremor, Anxiety, Irritability, Activities of Daily Living Impaired, Lack of Spontaneous Speech, Insomnia, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zoloft
Administration route: Oral
Indication: Depression
Start date: 2007-05-29
End date: 2007-07-05
Zyprexa
Administration route: Oral
Indication: Delusion
Start date: 2007-07-02
End date: 2007-07-02
Other drugs received by patient: Reslin; Pantosin; Magvit
Adverse event in 61 year old female receiving Zyprexa (Olanzapine)
Reported by a individual with unspecified qualification from United States on 2007-06-25
Patient: 61 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Pneumonia, Joint Sprain, Joint Dislocation, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Cerebrovascular Accident, Cardiac Failure Congestive
Adverse event resulted in: life threatening event
Suspect drug(s):
Zyprexa
Dosage: twice daily
Indication: Homeless
Start date: 2002-06-18
End date: 2002-06-25
Zyprexa
Dosage: twice daily
Indication: Sleep Disorder
Start date: 2002-06-18
End date: 2002-06-25
Haldol
Adverse event in 32 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from Japan on 2007-05-09
Patient: 32 year old male, weighing 61.5 kg (135.3 pounds)
Adverse reactions / side effects: Brain Herniation, Neuroleptic Malignant Syndrome, Eczema, Cardiac Arrest, Clonic Convulsion
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Zyprexa (Olanzapine)
Other drugs received by patient: Landsen; Akineton; Akineton; Akineton; Cercine; Cercine; Haloperidol; Haloperidol; Haloperidol; Anatensol; Gaster; Dantrium; Dantrium; Dantrium; Dantrium; Dantrium; Dantrium; Dantrium
Adverse event in 29 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from Norway on 2007-05-03
Patient: 29 year old male
Adverse reactions / side effects: Prescribed Overdose, Drug Interaction, Neuroleptic Malignant Syndrome, Leukopenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Zyprexa (Olanzapine)
Other drugs received by patient possibly interacting with the suspect drug:
Lithionit
Dosage: 83 mg morning + 166 mg evening (daily)
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2007-03-15
Other drugs received by patient: Rivotril; Valproate Sodium
Adverse event in 44 year old male receiving Zyprexa (Olanzapine)
Reported by a pharmacist from United States on 2007-04-25
Patient: 44 year old male
Adverse reactions / side effects: Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event
Suspect drug(s):
Prolixin
Dosage: 10 mg po bid
Administration route: Oral
Indication: Antisocial Personality Disorder
Start date: 2006-12-19
End date: 2007-01-15
Prolixin
Dosage: 10 mg po bid
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2006-12-19
End date: 2007-01-15
Seroquel
Dosage: see image
Administration route: Oral
Indication: Antisocial Personality Disorder
Start date: 2006-12-19
End date: 2007-01-15
Seroquel
Dosage: see image
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2006-12-19
End date: 2007-01-15
Zyprexa
Dosage: 5 mg po tid
Administration route: Oral
Indication: Antisocial Personality Disorder
Start date: 2006-12-21
End date: 2007-01-15
Zyprexa
Dosage: 5 mg po tid
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2006-12-21
End date: 2007-01-15
Other drugs received by patient: Benztropine; Chloral Hydrate; Clonazepam; Hydrochlorothiazide; Lorazepam; Valproic Acid
Adverse event in 60 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from Japan on 2007-04-11
Patient: 60 year old male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyprexa
Dosage: 20 mg, daily (1/d)
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-02-21
End date: 2007-02-25
Zyprexa
Dosage: 5 mg, daily (1/d)
Administration route: Oral
Start date: 2007-02-26
End date: 2007-02-28
Other drugs received by patient: Silece; NU-Lotan; Norvasc; Fluitran
Adverse event in 39 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from Japan on 2007-03-05
Patient: 39 year old male, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Polydipsia, Disseminated Intravascular Coagulation, Urinary Tract Infection, Thirst, Apallic Syndrome, Weight Increased, Staphylococcal Infection, Anorexia, Neuroleptic Malignant Syndrome, Respiratory Tract Infection, Diabetic Hyperosmolar Coma, Shock
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zyprexa (Olanzapine)
Other drugs received by patient: Prothiaden; Levotomin; Rohypnol; Limas; Halcion
Adverse event in 47 year old female receiving Zyprexa (Olanzapine)
Reported by a physician from United Kingdom on 2007-02-19
Patient: 47 year old female, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Agitation, Hyperthermia, Tachycardia, Liver Disorder, Blood Osmolarity Decreased, Overdose, Musculoskeletal Stiffness, Depression, Neuroleptic Malignant Syndrome, White Blood Cell Count Increased, Posturing, Fluid Imbalance, Blood Pressure Increased, Trismus, Abnormal Behaviour, Delirium, Tremor, Renal Impairment, Communication Disorder, Escherichia Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyprexa
Dosage: 15 mg, each evening
Indication: Psychotic Disorder
End date: 2007-01-01
Zyprexa
Dosage: 7.5 mg, each evening
Start date: 2007-01-01
End date: 2007-01-01
Zyprexa
Dosage: 2.5 mg, each evening
Administration route: Oral
Start date: 2007-01-11
End date: 2007-01-24
Other drugs received by patient: Sertraline; Lithium Carbonate; Paracetamol; Senna; Lactulose; Lactulose; Cefaclor; Procyclidine Hydrochloride 2MG TAB
Adverse event in 86 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from United Kingdom on 2007-02-01
Patient: 86 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Neuroleptic Malignant Syndrome, Leukocytosis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Zyprexa (Olanzapine)
Other drugs received by patient: Clopixol Depot; Priadel
Adverse event in 86 year old male receiving Zyprexa (Olanzapine)
Reported by a physician from United Kingdom on 2007-01-29
Patient: 86 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Neuroleptic Malignant Syndrome, Leukocytosis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Zyprexa (Olanzapine)
Other drugs received by patient: Clopixol Depot; Priadel
|
